drugset / Trial / NCT06953453

A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors

NCT06953453

Phase 1 Recruiting 100 enrolled Lee's Pharmaceutical Limited
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a single-dose, open-label, 2-cycle crossover design, comparing the pharmacokinetic parameters and safety of Inhaled Fentanyl Aerosol and intravenous fentanyl injection.

Timeline

Start
2025-09-23
Primary completion
2026-07-20
Completion
2026-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 25 ug Inhaled

Indications